GAS2
Basic information
Region (hg38): 11:22625509-22813001
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 0 | 1 |
Variants in GAS2
This is a list of pathogenic ClinVar variants found in the GAS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-22625510-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
11-22625510-G-C | Fanconi anemia | Uncertain significance (Jul 12, 2022) | ||
11-22625519-G-A | Fanconi anemia | Likely benign (Apr 28, 2023) | ||
11-22625520-C-G | Fanconi anemia | Likely benign (Nov 23, 2021) | ||
11-22625520-C-T | Fanconi anemia | Likely benign (Sep 09, 2022) | ||
11-22625526-CAG-C | Fanconi anemia complementation group F | Pathogenic (Jun 06, 2022) | ||
11-22625530-G-A | Fanconi anemia | Uncertain significance (Jan 24, 2022) | ||
11-22625530-G-C | Fanconi anemia | Uncertain significance (Sep 05, 2023) | ||
11-22625532-G-A | Fanconi anemia • Fanconi anemia complementation group F • not specified | Conflicting classifications of pathogenicity (Jul 26, 2023) | ||
11-22625535-C-G | Fanconi anemia | Likely benign (Oct 13, 2023) | ||
11-22625542-T-C | Fanconi anemia | Uncertain significance (Nov 28, 2023) | ||
11-22625542-TCA-T | Fanconi anemia complementation group F • Fanconi anemia | Pathogenic/Likely pathogenic (Aug 10, 2023) | ||
11-22625543-C-T | Fanconi anemia | Uncertain significance (Sep 29, 2021) | ||
11-22625544-A-G | Fanconi anemia | Likely benign (Jan 12, 2024) | ||
11-22625547-GTGA-G | Fanconi anemia | Uncertain significance (Jun 14, 2016) | ||
11-22625551-C-A | Fanconi anemia | Uncertain significance (Jul 19, 2022) | ||
11-22625553-G-A | Fanconi anemia | Likely benign (Aug 24, 2022) | ||
11-22625553-G-T | Fanconi anemia | Likely benign (Dec 04, 2023) | ||
11-22625555-G-A | not specified | not provided (Sep 19, 2013) | ||
11-22625558-C-T | Fanconi anemia | Uncertain significance (Jan 18, 2022) | ||
11-22625558-CCTGGAAGTTCGCTAATCCCGGAA-C | Fanconi anemia complementation group F • Fanconi anemia | Pathogenic (Feb 06, 2024) | ||
11-22625560-T-C | Fanconi anemia | Uncertain significance (Aug 20, 2020) | ||
11-22625562-G-A | Fanconi anemia | Likely benign (Nov 08, 2022) | ||
11-22625563-A-G | Fanconi anemia complementation group F | Uncertain significance (Apr 04, 2024) | ||
11-22625565-G-A | Fanconi anemia • not specified | Benign/Likely benign (Jan 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GAS2 | protein_coding | protein_coding | ENST00000454584 | 7 | 187414 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000802 | 0.985 | 125730 | 0 | 17 | 125747 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.440 | 154 | 170 | 0.905 | 0.00000876 | 2039 |
Missense in Polyphen | 39 | 56.149 | 0.69457 | 641 | ||
Synonymous | 0.161 | 60 | 61.6 | 0.974 | 0.00000312 | 599 |
Loss of Function | 2.15 | 8 | 17.8 | 0.449 | 0.00000110 | 201 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000176 | 0.000176 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000706 | 0.0000703 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in apoptosis by acting as a cell death substrate for caspases. Is cleaved during apoptosis and the cleaved form induces dramatic rearrangements of the actin cytoskeleton and potent changes in the shape of the affected cells. May be involved in the membrane ruffling process (By similarity). {ECO:0000250}.;
- Pathway
- induction of apoptosis through dr3 and dr4/5 death receptors;Caspase-mediated cleavage of cytoskeletal proteins;Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Caspase Cascade in Apoptosis
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.724
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.82
Haploinsufficiency Scores
- pHI
- 0.536
- hipred
- Y
- hipred_score
- 0.617
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.845
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gas2
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- initiation of primordial ovarian follicle growth;antral ovarian follicle growth;apoptotic process;cell cycle arrest;regulation of cell shape;regulation of Notch signaling pathway;ovulation;basement membrane organization
- Cellular component
- cytosol;actin filament;membrane
- Molecular function
- microtubule binding